| Jokha A Ahmed, MD | |
|
295 Varnum Ave, Lowell, MA 01854-2134 | |
| (978) 937-6000 | |
| (301) 618-2986 |
| Full Name | Jokha A Ahmed |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 13 Years |
| Location | 295 Varnum Ave, Lowell, Massachusetts |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306369749 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0300X | Internal Medicine - Geriatric Medicine | 287620 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lowell General Hospital | Lowell, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lowell General Inpatient Specialists Pllc | 8729371380 | 53 |
News Archive
Today's headlines include reports about how Republicans are positioning themselves to capitalize on the health law's implementation difficulties in the upcoming election season.
Scientists are reporting an in-depth validation of the discovery of the world's first mass producible, low-cost, organoclays for plastics. The powdered material, made from natural clay, would be a safer, more environmentally friendly replacement for the compound widely used to make plastics nanocomposites. A report on the research appears in ACS' Macromolecules, a bi-weekly journal.
Medgenics, Inc., the developer of a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, today reported financial results for the three and six months ended June 30, 2011.
Endo Pharmaceuticals has submitted a complete response to the U.S. Food and Drug Administration (FDA) following the company's receipt of a Complete Response letter in October 2009 related to the New Drug Application (NDA) submission for FORTESTA™ (testosterone) 2% gel. The company's Class 2 resubmission is the next step in its intention to offer FORTESTA as a treatment option in the United States for men diagnosed with low testosterone (Low T), also known as hypogonadism. The FDA's review period for Class 2 resubmissions typically is six months.
› Verified 6 days ago
| Entity Name | Lowell General Inpatient Specialists Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649626391 PECOS PAC ID: 8729371380 Enrollment ID: O20160720001673 |
News Archive
Today's headlines include reports about how Republicans are positioning themselves to capitalize on the health law's implementation difficulties in the upcoming election season.
Scientists are reporting an in-depth validation of the discovery of the world's first mass producible, low-cost, organoclays for plastics. The powdered material, made from natural clay, would be a safer, more environmentally friendly replacement for the compound widely used to make plastics nanocomposites. A report on the research appears in ACS' Macromolecules, a bi-weekly journal.
Medgenics, Inc., the developer of a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, today reported financial results for the three and six months ended June 30, 2011.
Endo Pharmaceuticals has submitted a complete response to the U.S. Food and Drug Administration (FDA) following the company's receipt of a Complete Response letter in October 2009 related to the New Drug Application (NDA) submission for FORTESTA™ (testosterone) 2% gel. The company's Class 2 resubmission is the next step in its intention to offer FORTESTA as a treatment option in the United States for men diagnosed with low testosterone (Low T), also known as hypogonadism. The FDA's review period for Class 2 resubmissions typically is six months.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jokha A Ahmed, MD 47 High Street, Suite 101, North Andover, MA 01845 Ph: (978) 258-4734 | Jokha A Ahmed, MD 295 Varnum Ave, Lowell, MA 01854-2134 Ph: (978) 937-6000 |
News Archive
Today's headlines include reports about how Republicans are positioning themselves to capitalize on the health law's implementation difficulties in the upcoming election season.
Scientists are reporting an in-depth validation of the discovery of the world's first mass producible, low-cost, organoclays for plastics. The powdered material, made from natural clay, would be a safer, more environmentally friendly replacement for the compound widely used to make plastics nanocomposites. A report on the research appears in ACS' Macromolecules, a bi-weekly journal.
Medgenics, Inc., the developer of a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, today reported financial results for the three and six months ended June 30, 2011.
Endo Pharmaceuticals has submitted a complete response to the U.S. Food and Drug Administration (FDA) following the company's receipt of a Complete Response letter in October 2009 related to the New Drug Application (NDA) submission for FORTESTA™ (testosterone) 2% gel. The company's Class 2 resubmission is the next step in its intention to offer FORTESTA as a treatment option in the United States for men diagnosed with low testosterone (Low T), also known as hypogonadism. The FDA's review period for Class 2 resubmissions typically is six months.
› Verified 6 days ago
Alexandra Miniati, MD Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 275 Varnum Ave Riverside Medical Group, Ste 201, Lowell, MA 01854 Phone: 978-452-9700 Fax: 978-441-6075 | |
Dr. Cynthia Lynn Manning, M.D. Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 295 Varnum Ave, Lowell, MA 01854 Phone: 978-937-6439 | |
Mrs. Frances M Morse, MD Geriatric Medicine Medicare: Not Enrolled in Medicare Practice Location: 275 Varnum Ave, Ste 101, Lowell, MA 01854 Phone: 978-459-0531 Fax: 978-459-8389 | |
Mrs. Sara Larson Clay, MD Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 275 Varnum Ave, Ste 201, Lowell, MA 01854 Phone: 978-452-9700 Fax: 978-441-6075 | |
Riad Ettunsi, Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 295 Varnum Ave, Lowell, MA 01854 Phone: 978-937-6000 | |
Peter S Bradshaw, M.D. Geriatric Medicine Medicare: Medicare Enrolled Practice Location: 77 E Merrimack St, Suite 15, Lowell, MA 01852 Phone: 978-459-3341 | |
Seema Sahib, MD Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 295 Varnum Ave # General, Lowell, MA 01854 Phone: 978-937-6439 |